Daclizumab has 2 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Ocrelizumab, Ocrelizumab And Hyaluronidase. Patients taking Daclizumab should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Moderate
- 2
Moderate (2)
- Daclizumab + Ocrelizumab— Concomitant use may cause additive immunosuppressive effects. Consider duration and mode of action when switching from d…
- Daclizumab + Ocrelizumab And Hyaluronidase— Concomitant use may increase risk of additive immunosuppressive effects due to prolonged immune effects of daclizumab. C…